Respuesta inmune a los oncornavirus de primates en la preeclampsia.

Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.

Gynecologic oncology·2009

National survey on cholecystectomy related bile duct injury--public health and financial aspects in Belgian hospitals--1997.

Acta chirurgica Belgica·2003

Human recombinant myeloperoxidase antiviral activity on cytomegalovirus.

Journal of medical virology·2002

[Antibiotics and pregnancy].

Revue medicale de Bruxelles·2001

['Evidence-based' perioperative antibiotic prophylaxis policy in Belgian hospitals after a change in the reimbursement system].

Nederlands tijdschrift voor geneeskunde·2001

Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Healthcare professionals' perspectives and preferences regarding adolescent meningococcal disease vaccination in the United States.

Expert review of vaccines·2026

A Nationwide Review of the Utilization of Rapid Antigen Testing for Group A Streptococcus.

Cureus·2026

Homozygous familial hypercholesterolemia, experience with Evinacumab treatment in two Mexican pediatric patients: case report.

Frontiers in genetics·2026

Psychiatric and medical profiles of children receiving health protection measures in a tertiary care facility: A five-year analysis.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Predictors of parental stress in families of children with neurodevelopmental disabilities.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Venous malformation with localized intravascular coagulopathy in children treated with sclerotherapy and LWMH.

Frontiers in pediatrics·2026

Videos de Experimentos Relacionados

Respuesta inmune a los oncornavirus de primates en la preeclampsia.

Videos de Conceptos Relacionados

Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.

National survey on cholecystectomy related bile duct injury--public health and financial aspects in Belgian hospitals--1997.

Human recombinant myeloperoxidase antiviral activity on cytomegalovirus.

[Antibiotics and pregnancy].

['Evidence-based' perioperative antibiotic prophylaxis policy in Belgian hospitals after a change in the reimbursement system].

Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Healthcare professionals' perspectives and preferences regarding adolescent meningococcal disease vaccination in the United States.

A Nationwide Review of the Utilization of Rapid Antigen Testing for Group A Streptococcus.

Homozygous familial hypercholesterolemia, experience with Evinacumab treatment in two Mexican pediatric patients: case report.

Psychiatric and medical profiles of children receiving health protection measures in a tertiary care facility: A five-year analysis.

Predictors of parental stress in families of children with neurodevelopmental disabilities.

Venous malformation with localized intravascular coagulopathy in children treated with sclerotherapy and LWMH.

Videos de Experimentos Relacionados

Respuesta inmune a los oncornavirus de primates en la preeclampsia.

Videos de Conceptos Relacionados

Artículos Relacionados